ULURU Inc. announced the expansion of the Altrazeal international marketing network. An agreement has been signed granting the exclusive marketing and distribution rights for Altrazeal in Germany. The company plans to expand the marketing and distribution of Altrazeal to include Germany.

The extensive marketing experience it has gained with its partners in other European markets, together with the increased exposure Altrazeal has received at regional, national and European wound management meetings will be invaluable for the launch of Altrazeal in Germany. The continued expansion of clinical support data in numerous acute and chronic wounds, together with its expanding data base supporting the economic benefits of Altrazeal will also be very supportive of the Germany marketing activities.